Combination of sorafenib, vorinostat and bortezomib for the treatment of poor-risk AML: report of two consecutive clinical trials

Hamid Sayar, Larry Cripe, Antoine N. Saliba, Mohammad Abu Zaid, Heiko Konig, H. Boswell

Research output: Contribution to journalLetter

1 Citation (Scopus)
Original languageEnglish (US)
Pages (from-to)30-33
Number of pages4
JournalLeukemia Research
Volume77
DOIs
StatePublished - Feb 1 2019

Fingerprint

Acute Myeloid Leukemia
Clinical Trials
vorinostat
sorafenib
Bortezomib

Keywords

  • Acute myeloid leukemia
  • AML
  • Bortezomib
  • Sorafenib
  • Vorinostat

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this

Combination of sorafenib, vorinostat and bortezomib for the treatment of poor-risk AML : report of two consecutive clinical trials. / Sayar, Hamid; Cripe, Larry; Saliba, Antoine N.; Abu Zaid, Mohammad; Konig, Heiko; Boswell, H.

In: Leukemia Research, Vol. 77, 01.02.2019, p. 30-33.

Research output: Contribution to journalLetter

@article{fadf8114bf2141b9ad84afa24692085e,
title = "Combination of sorafenib, vorinostat and bortezomib for the treatment of poor-risk AML: report of two consecutive clinical trials",
keywords = "Acute myeloid leukemia, AML, Bortezomib, Sorafenib, Vorinostat",
author = "Hamid Sayar and Larry Cripe and Saliba, {Antoine N.} and {Abu Zaid}, Mohammad and Heiko Konig and H. Boswell",
year = "2019",
month = "2",
day = "1",
doi = "10.1016/j.leukres.2018.12.011",
language = "English (US)",
volume = "77",
pages = "30--33",
journal = "Leukemia Research",
issn = "0145-2126",
publisher = "Elsevier Limited",

}

TY - JOUR

T1 - Combination of sorafenib, vorinostat and bortezomib for the treatment of poor-risk AML

T2 - report of two consecutive clinical trials

AU - Sayar, Hamid

AU - Cripe, Larry

AU - Saliba, Antoine N.

AU - Abu Zaid, Mohammad

AU - Konig, Heiko

AU - Boswell, H.

PY - 2019/2/1

Y1 - 2019/2/1

KW - Acute myeloid leukemia

KW - AML

KW - Bortezomib

KW - Sorafenib

KW - Vorinostat

UR - http://www.scopus.com/inward/record.url?scp=85059451681&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85059451681&partnerID=8YFLogxK

U2 - 10.1016/j.leukres.2018.12.011

DO - 10.1016/j.leukres.2018.12.011

M3 - Letter

C2 - 30626561

AN - SCOPUS:85059451681

VL - 77

SP - 30

EP - 33

JO - Leukemia Research

JF - Leukemia Research

SN - 0145-2126

ER -